to control bipolar mood disorder where periods of mania alternate with periods of depression. Carbamazepine Sandoz belongs to ... the controlled release (CR) tablets, it may take longer for ...
Basel, February 24, 2025 – Sandoz (SIX:SDZ/OTCQX:SDZNY), the global leader in generic and biosimilar medicines, announces the launch of Pyzchiva®* (ustekinumab-ttwe) in the US.From today, the ...
Avecho retains the rights to commercialise the product in all other territories, with Sandoz granted a first right of refusal for these markets. Avecho's CBD capsule aims to be the first ...